APA (7th ed.) Citation

K, H., JY, J., M, M., S, E., N, C., SP, H., . . . NR, B. (2015). Population pharmacokinetics and dosing implications for cobimetinib in patients with solid tumors. Cancer chemotherapy and pharmacology, 76(5), 917. https://doi.org/10.1007/s00280-015-2862-0

Chicago Style (17th ed.) Citation

K, Han, et al. "Population Pharmacokinetics and Dosing Implications for Cobimetinib in Patients with Solid Tumors." Cancer Chemotherapy and Pharmacology 76, no. 5 (2015): 917. https://doi.org/10.1007/s00280-015-2862-0.

MLA (9th ed.) Citation

K, Han, et al. "Population Pharmacokinetics and Dosing Implications for Cobimetinib in Patients with Solid Tumors." Cancer Chemotherapy and Pharmacology, vol. 76, no. 5, 2015, p. 917, https://doi.org/10.1007/s00280-015-2862-0.